Magnetic seizure therapy is efficacious and well tolerated for treatment-resistant bipolar depression: an open-label clinical trial

作者
Victor M. Tang,Daniel M. Blumberger,Julia Dimitrova,Alanah Throop,Shawn M. McClintock,Daphne Voineskos,Jonathan H. Downar,Yuliya Knyahnytska,Benoit H. Mulsant,Paul Bernard Fitzgerald,Zafiris Jeff Daskalakis
出处
期刊:Journal of Psychiatry & Neuroscience [Canadian Science Publishing]
卷期号:45 (5): 313-321 被引量:22
标识
DOI:10.1503/jpn.190098
摘要

Background: Treatment-resistant bipolar depression can be treated effectively using electroconvulsive therapy, but its use is limited because of stigma and cognitive adverse effects. Magnetic seizure therapy is a new convulsive therapy with promising early evidence of antidepressant effects and minimal cognitive adverse effects. However, there are no clinical trials of the efficacy and safety of magnetic seizure therapy for treatment-resistant bipolar depression. Methods: Participants with treatment-resistant bipolar depression were treated with magnetic seizure therapy for up to 24 sessions or until remission. Magnetic seizure therapy was applied over the prefrontal cortex at high (100 Hz; n = 8), medium (50 or 60 Hz; n = 9) or low (25 Hz; n = 3) frequency, or over the vertex at high frequency (n = 6). The primary outcome measure was the 24-item Hamilton Rating Scale for Depression. Participants completed a comprehensive battery of neurocognitive tests. Results: Twenty-six participants completed a minimally adequate trial of magnetic seizure therapy (i.e., ≥ 8 sessions), and 20 completed full treatment per protocol. Participants showed a significant reduction in scores on the Hamilton Rating Scale for Depression. Adequate trial completers had a remission rate of 23.1% and a response rate of 38.5%. Per-protocol completers had a remission rate of 30% and a response rate of 50%. Almost all cognitive measures remained stable, except for significantly worsened recall consistency on the autobiographical memory inventory. Limitations: The open-label study design and modest sample size did not allow for comparisons between stimulation parameters. Conclusion: In treatment-resistant bipolar depression, magnetic seizure therapy produced significant improvements in depression symptoms with minimal effects on cognitive performance. These promising results warrant further investigation with larger randomized clinical trials comparing magnetic seizure therapy to electroconvulsive therapy. Clinical trial registration: NCT01596608; clinicaltrials.gov

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
寂寞的面包完成签到 ,获得积分10
刚刚
飘逸山兰完成签到,获得积分10
刚刚
吴锋发布了新的文献求助10
刚刚
懵懂的弱完成签到,获得积分10
刚刚
狗崽崽完成签到,获得积分10
1秒前
ii完成签到,获得积分10
1秒前
songzx完成签到,获得积分10
1秒前
他是一只咕咕鸡完成签到,获得积分10
1秒前
南宫无血完成签到,获得积分10
1秒前
uuuu完成签到 ,获得积分10
2秒前
一颗苹果的应助被周辰采纳,获得10
2秒前
锅锅完成签到,获得积分10
3秒前
XiaoMing完成签到,获得积分10
3秒前
水水完成签到 ,获得积分10
3秒前
小安完成签到,获得积分10
4秒前
永溺深海的猫完成签到,获得积分10
4秒前
敏感笑槐完成签到 ,获得积分10
4秒前
完美世界的应助被Jim采纳,获得10
4秒前
玖雾完成签到,获得积分10
5秒前
ltt发布了新的文献求助20
5秒前
你说什么我听不见完成签到,获得积分10
5秒前
5秒前
5秒前
初(*^▽^*)心的应助被NiaoJiang采纳,获得10
5秒前
Star1983完成签到,获得积分10
5秒前
5秒前
槐夏十三完成签到 ,获得积分10
6秒前
jiangxiaoxu完成签到,获得积分10
6秒前
chilin完成签到,获得积分10
6秒前
郭濹涵完成签到,获得积分10
7秒前
Saoirse完成签到 ,获得积分10
8秒前
传统的寒凝完成签到,获得积分10
8秒前
WX完成签到,获得积分10
9秒前
gaoxiansheng完成签到,获得积分10
9秒前
9秒前
guoke完成签到,获得积分10
10秒前
123发布了新的文献求助10
10秒前
dhn123完成签到,获得积分10
11秒前
ve完成签到 ,获得积分10
11秒前
Yan完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180135
求助须知:如何正确求助?哪些是违规求助? 9570290
关于积分的说明 21809391
捐赠科研通 7776237
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557465
邀请新用户注册赠送积分活动 2479039